1. BCLA CLEAR Presbyopia: Evaluation and diagnosis.
- Author
-
Wolffsohn JS, Berkow D, Chan KY, Chaurasiya SK, Fadel D, Haddad M, Imane T, Jones L, Sheppard AL, Vianya-Estopa M, Walsh K, Woods J, Zeri F, and Morgan PB
- Subjects
- Humans, Contact Lenses, Accommodation, Ocular physiology, Corneal Topography, Visual Acuity physiology, Refraction, Ocular physiology, Eyeglasses, Presbyopia diagnosis, Presbyopia physiopathology, Presbyopia therapy
- Abstract
It is important to be able to measure the range of clear focus in clinical practice to advise on presbyopia correction techniques and to optimise the correction power. Both subjective and objective techniques are necessary: subjective techniques (such as patient reported outcome questionnaires and defocus curves) assess the impact of presbyopia on a patient and how the combination of residual objective accommodation and their natural DoF work for them; objective techniques (such as autorefraction, corneal topography and lens imaging) allow the clinician to understand how well a technique is working optically and whether it is the right choice or how adjustments can be made to optimise performance. Techniques to assess visual performance and adverse effects must be carefully conducted to gain a reliable end-point, considering the target size, contrast and illumination. Objective techniques are generally more reliable, can help to explain unexpected subjective results and imaging can be a powerful communication tool with patients. A clear diagnosis, excluding factors such as binocular vision issues or digital eye strain that can also cause similar symptoms, is critical for the patient to understand and adapt to presbyopia. Some corrective options are more permanent, such as implanted inlays / intraocular lenses or laser refractive surgery, so the optics can be trialled with contact lenses in advance (including differences between the eyes) to better communicate with the patient how the optics will work for them so they can make an informed choice., Competing Interests: Declaration of competing interest James S. Wolffsohn has received grant funding from Alcon and Rayner, is a paid consultant for Alcon, Atia Vision and Bausch + Lomb, and has stock ownership in Wolffsohn Research Ltd. Ka Yin Chan is an employee of Johnson & Johnson Vision. Daddi Fadel has received honoraria from AOS Software, Appenzeller Kontaklinsen, Augmented Vision Labs, Bausch + Lomb, Boston Materials, Bostonsight, Chio by Cliara, Contamac, DMV, Eaglet Eye, EasyLac, Medlac, Medmont, Menicon, Multilens, Occhio x Occhio, Oculus, Optiforum, Scleral Lens Society, Scope, Swisslens, Topcon healthcare, and Wave Software. Lyndon Jones has provided consultancy for Alcon, CooperVision, J&J Vision, Novartis and Ophtecs and received grant funding from Alcon, Allied Innovations, Azura Ophthalmics, Bausch Health, CooperVision, Essilor, Hoya, i-Med Pharma, Johnson & Johnson Vision, Menicon, Novartis, Ophtecs, Oté Pharma, Santen, SightGlass, SightSage, Topcon and Visioneering. Karen Walsh is an employee and has stock ownership of CooperVision. Fabrizio Zeri has provided consultancy for Assottica, Alcon, Bausch + Lomb, CSO, Essilor, Grand Vision, Johnson & Johnson Vison and had grant funding from Alcon, CSO and Hoya. Philip B Morgan has received honoraria from Alcon, Bausch + Lomb, CooperVision, Menicon and Johnson & Johnson Vision and grant funding from Alcon, Bausch + Lomb, Clearlab, CooperVision, Daysoft, Johnson & Johnson Vision, Mark'Ennovy, Menicon and Visco Vision. David Berkow, Suraj K. Chaurasiya, Mera Haddad, Tarib Imane, Amy L. Sheppard, Marta Vianya-Estopa and Jill Woods have no declarations of competing interest., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF